Rj 2.2.5, a variant of the human B-lymphoma cell line Raji, does not express the HLA-DR, -DQ, and -DP class H (or la) histocompatibility antigens, as a result of a defect in the transcription of the corresponding genes. This defect is corrected after fusion of Rj 2.2.5 cells with mouse Ia-positive cells. Previous work showed that the trans-acting transcriptional activator supplied by the mouse cells is encoded by a locus on mouse chromosome 16. We show here that reexpression of human mnjor histocompatibility complex class II genes by RJ 2.2.5 cells can also be achieved by stable integration of mouse genomic sequences into the RJ 2.2.5 genome after DNA-mediated gene transfer.
The HLA-D region of the human major histocompatibility complex (MHC) encodes highly polymorphic heterodimeric glycoproteins (class II or Ia antigens) that play an important role in the homeostasis of the immune response (1) . The HLA-D region encompasses at least three subregions (DR, DQ, and DP) each containing multiple nonallelic a-and ,lchain genes (2, 3) . Class II gene products are expressed primarily on B cells, macrophages, and activated T cells (4) . Studies on the distribution and regulation of the genes for MHC class II antigens have suggested the existence of cell-specific as well as gene-specific control mechanisms (reviewed in ref. 2 ). B-cell Ia-negative variants have been isolated in which there is a simultaneous loss of expression of all class II genes, without deletion of the structural genes (5-7), thus suggesting that class II genes are coordinately regulated at least in B cells. Previous reports described the isolation and characterization of an Ia-negative variant of the B-lymphoma cell line Raji, designated RJ 2.2.5 (5) , that does not express DR, DQ, and DP antigens because of the lack of specific messenger RNA (6) . Such a defect can be complemented by fusion of variant RJ 2.2.5 with the murine Ia-positive B-lymphoma cell line M12.4.1 (8) or with mouse spleen cells (9) . Analysis of marker segregation in the hybrids obtained by fusing RJ 2.2.5 cells with mouse spleen cells has led to the conclusion that expression of the HLA-DR, -DQ and -DP genes requires the presence of a trans-acting positive factor that can be supplied by a murine locus that lies outside the MHC region (9) . Subsequent analysis has shown that this locus, which we call aIr-l (for activator of Immune-response genes locus 1), is syntenic with markers of mouse chromosome 16 (10) . The fact that the Ia expression of RJ 2.2.5 cells can be restored by introduction of a murine genetic element prompted us to devise a complementation assay based on DNA-mediated gene transfer. This assay, greatly facilitated by the remarkable stability of the phenotype of the RJ 2.2.5 variant, showed that stable integration of mouse genomic DNA into RJ 2.2.5 cells allows reexpression of human class II genes. The findings presented here suggest it will be possible to isolate the regulatory gene involved in the control of major histocompatibility class II gene expression.
MATERIALS AND METHODS
Cells and Monoclonal Antibodies. The human Ia-negative B-cell line RJ 2.2.5 (5) was used in this study. High molecular weight DNA for transfection experiments was from murine M12.4.1 lymphoma cells (11) . Cells were propagated in RPMI 1640 medium supplemented with 10% fetal bovine serum and 280 mM glutamine.
The monoclonal antibodies (mAbs) used in this study were D1-12, specific for DR molecules (12) , and BT3/4, specific for DQ1 molecules (13) .
Transfection Method. RJ 2.2.5 cells (2 x 107) in 50 ml of RPMI 1640 medium supplemented with 10% fetal bovine serum were treated with 150 ,zg of high molecular weight genomic DNA. The DNA was first dissolved in 12.5 ml of 20 mM Hepes, pH 7.1/137 mM NaCl/0.7 mM Na2HPO4/0.7 mM NaH2PO4/116 mM MgCl2/27 mM CaCl2. The DNA suspension was incubated for 30 min at room temperature and then slowly added to the cells. The mixture of cells and DNA was incubated overnight at 37°C and 5% CO2. The cells were then washed and resuspended in complete medium for 24 hr. At this stage, the DR-positive cells were enriched by "panning" (30 min incubation at 4°C) on ordinary Petri dishes coated with D1-12 mAb. After the panning step, cells were detached by washing, incubated with D1-12 mAb followed by a fluorescein-conjugated second antibody, and analyzed on a fluorescence-activated cell sorter (FACS II, Becton Dickinson) as described (5) . DR-positive cells were FACSsorted, plated on irradiated' mouse macrophages, propagated in culture for 2-3 weeks, and then FACS-sorted as above.
DNA Purification and Hybridization. High molecular weight genomic DNA was purified as described (8) . Aliquots (10 ,ug) were digested with HindIII restriction enzyme (Boehringer Mannheim) and electrophoresed in a 0.7% agarose gel at 100 V. The gel was then soaked in 0.25 M HCl for 30 min and transferred to a solution containing 0.4 M NaOH and 0.6 M NaCl for an additional 30 min. The DNA was then blotted onto a GeneScreenPlus membrane (New England Nuclear) by an alkaline transfer method according to the specification of the manufacturer. The filter was prehybridized in the presence of human DNA (10 ,ug/ml) and Escherichia coli K-12 tRNA (100 ,ug/ml) and hybridized with an [a-32P]dNTP-labeled DNA probe (specific activity S X 108 cpm/,g). The labeled probe consisted of genomic DNA purified from mouse liver; the purified DNA was sonicated for 3 min in order to reduce its molecular length to 0.2-0.4
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kilobases and further purified on a CsCl gradient before labeling.
RESULTS
Transfection of RJ 2.2.5 Cells with Mouse Genomic DNA. Transfection of Raji cells, and thus of RJ 2.2.5 cells, has not been extensively explored so far because the frequency of transfection is low when assayed using vectors carrying selectable markers (14) . In our hands, preliminary tests showed that toxicity of the chemicals employed in typical transfection protocols, such as Ca2+, DEAE-dextran, polyethylene glycol contributed to the poor yield of transfectants observed when RJ 2.2.5 cells are used as recipients (data not shown). Moreover, the minimal inhibitory concentration of drugs used for positive selection, such as the neomycin analogue G418, could not be determined precisely, as it was influenced by subtle variations of cell growth conditions, thus making it difficult to devise proper selective media. To overcome these problems, the following strategy was adopted. First, transfection conditions were selected to minimize toxicity; the final conditions were derived from the calcium coprecipitation method (15) , except that the Ca2+ concentration was lowered and the total amount of divalent ions was kept constant by addition of MgCl2 (see Materials and Methods). Second, the ability of the transfected cells to transiently express new, relevant surface markers was determined by fluorocytometry 48 hr after exposure of the cells to the DNA. Methods based on the detection of transfectants by FACS analysis have already been successfully exploited for transfection (both transient and permanent) of genes coding for cell-lineage-specific surface antigens (16, 17) . In these instances total genomic DNA was used and a high number of cells were found to transiently express the relevant antigens within 48-72 hr after transfection. In our study, the expression of a mouse marker (H-2K) as well as human DR molecules by RJ 2.2.5 cells was monitored 48 hr after transfection of these cells with DNA from the mouse Blymphoma cell line M12.4.1. The fraction of the population capable of expressing the above antigens upon transfection varied from 6% to 15% for H-2K and 3% to 37% for DR antigens (data not shown). These frequencies are similar to those reported by other investigators under different experimental situations (16, 17) . In one experiment, referred to as T-V (transfection 5), the cells that were positive for DR antigens 48 hr after transfection were enriched by panning on D1-12 (a DR-specific mAb)-coated Petri dishes. "Panned" cells were stained with D1-12 mAb, FACS-sorted, and cultured. This population was called T-V S1 (transfection 5, sorting 1). The cultured cells were retested after 2-3 weeks for DR expression and then FACS-sorted again on the basis of this phenotype. This procedure was repeated several times. The percentage of DR-positive "transfected" cells increased progressively as a function of the number of sorting cycles, so that more than 95% of the population was positive after sorting 4 (Fig. 1) . The calculated frequency (17) of transfection under these conditions was 0.8 x 10-3 (Table 1) .
Not only the selected DR marker but also the nonselected DQ marker was expressed in the transfected population (Fig. 1) DNA rearrangements involving HLA-DR and HLA-DQ aand P-chain genes.
The ability of mouse M12.4.1 DNA to complement the regulatory defect of RJ 2.2.5 cells was confirmed in an independent transfection experiment, T-XIV, that gave results (not shown) comparable to those obtained in T-V. The DNA extracted from T-V transfectants at different stages of purification and from T-XIV was examined for the presence of mouse DNA repetitive sequences. T-V cells analyzed after sorting 2, when two-thirds of the cells were still DR-negative (Fig. 2, lane b) and T-V cells collected after sorting 4, when at least 95% of the cells were DR-positive (lane a) still retained mouse DNA repetitive sequences. Similarly, T-XIV Fig. 3 shows the results obtained with the secondary transfectant T-XI. A clear biphasic distribution of DR-positive and DR-negative cells was already evident after sorting 3. After four sorting cycles, more than 95% ofthe cells expressed human class II markers. The DR-specific fluorescence shown by T-XI S5 was about 3-fold higher than that exhibited by T-V S5 and similar to that measured in Raji cells. Reexpression of DR and DQ antigens was observed (Fig. 3) . The frequency of transfection observed in T-XI was similar to that calculated for T-V (Table  1) . Clones reexpressing human la antigens were derived from the T-XI S5 population by micromanipulation and analyzed for their DNA content. The genomic DNA extracted from one of these clones, T-XI S5.7, contained mouse repetitive DNA sequences (Fig. 2, lane d) . Both the degree and the pattern of hybridization of T-XI S5.7 DNA for mouse repetitive sequences were different when compared to DNA of T-V S4 cells, from which the T-XI transfectant was generated.
This finding is probably explained by a selective enrichment and/or amplification of specific mouse sequences derived from T-V DNA in the T-XI S5. and (it) back-mutation to Ia positivity induced by a mutagenic effect of the incoming DNA on the resident DNA.
Spontaneous reversion rate was measured by treating RJ 2.2.5 cells exactly as in a transfection experiment but in the absence of DNA. The population derived from such an experiment was called T-XIII. At each sorting cycle the most positive cells were collected (Fig. 4 Right). After one panning and six sorting cycles, the mean fluorescence intensity for DR of T-XIII S6 was 8, in arbitrary units, vs. a mean of 4 for T-XIII S4 and RJ 2.2.5 cells. Under the same conditions, the mean was 30 for T-V S4 and 85 for T-XI S5. No biphasic distribution was observed in T-XIII even after six sorting cycles (Fig. 4) . The meaning of the 2-fold increase in fluorescence intensity observed in T-XIII S5 and S6 as compared to T-XIII S4 is unclear. Such an increase may reflect either the selection of a cell population with a higher nonspecific background or a reversion to low Ia positivity. In either case, however, the frequency of the event would not be higher than 2 x 10-8 (see Table 1 ), 4 to 5 orders of magnitude lower than the frequency of transfection observed in T-V.
A possible mutagenic effect of the incoming DNA on the recipient genome was investigated by transfecting RJ 2.2.5 cells with autologous DNA. As shown in Fig. 4 The results presented in this paper strengthen the proposal that the transcriptional factor required for the trans-activation of the human class II genes can be substituted for by the products of a dominantly expressed murine gene(s) that, as reported elsewhere (8, 9) , also affects the expression of mouse class II genes in normal spleen cells. The finding that transfection with mouse DNA suppresses the phenotype of RJ 2.2.5 cells opens the way to a direct approach for isolation of the trans-acting class II activator gene.
